申请人:Shutske Gregory
公开号:US20070099955A1
公开(公告)日:2007-05-03
The present invention provides compounds of formula I:
a stereoisomer or a pharmaceutically acceptable salt thereof, wherein the variables R
1
, R
2
, R
3
, R
4
, X and n are defined as defined herein. Additionally, a method for treating dopamine-related neurological disorders selected form the group consisting of neurological, psychological, cardiovascular, cognitive or attention disorders, substance abuse and addictive behavior, or a combination thereof, comprising administering to a patient in need of such treatment a therapeutically effective amount of compounds of formula I.
本发明提供了公式I的化合物:其立体异构体或其药学上可接受的盐,其中变量R1,R2,R3,R4,X和n如本文所定义。此外,本发明还提供了一种治疗多巴胺相关神经疾病的方法,所述疾病选自神经、心理、心血管、认知或注意力障碍、物质滥用和成瘾行为或其组合,包括向需要此类治疗的患者投与公式I的化合物的治疗有效量。